Free Trial

Xeris Biopharma (XERS) Earnings Date, Estimates & Call Transcripts

Xeris Biopharma logo
$3.06 +0.05 (+1.66%)
(As of 11/20/2024 ET)
Get Xeris Biopharma Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Xeris Biopharma and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

XERS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

XERS Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Xeris Biopharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242-$0.14-$0.11-$0.13
Q2 20242-$0.11-$0.11-$0.11
Q3 20242-$0.12-$0.10-$0.11
Q4 20242-$0.08-$0.07-$0.08
FY 20248($0.45)($0.39)($0.42)

Xeris Biopharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
3/5/2025
(Estimated)
------- 
8/8/2024Q2 2024-$0.11-$0.10+$0.01-$0.10$46.80M$48.07M      
5/9/2024Q1 2024-$0.12-$0.14 -$0.02-$0.14$41.56M$40.64M      
3/6/2024Q4 2023-$0.09-$0.10 -$0.01-$0.10$45.50M$44.39M      
11/9/2023Q3 2023-$0.12-$0.09+$0.03-$0.09$40.93M$48.32M  
8/8/2023Q2 2023-$0.13-$0.14 -$0.01-$0.14$34.84M$38.01M  
5/9/2023Q1 2023-$0.17-$0.12+$0.05-$0.12$30.77M$33.20M  
3/8/2023Q4 2022-$0.16-$0.10+$0.06-$0.10$31.04M$33.14M  

Xeris Biopharma Earnings - Frequently Asked Questions

Xeris Biopharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, March 5th, 2025 based off last year's report dates. Learn more on XERS's earnings history.

Xeris Biopharma issued an update on its FY 2024 earnings guidance on Friday, November, 8th. The company issued revenue guidance of $198.0 million-$202.0 million, compared to the consensus revenue estimate of $193.4 million.

Xeris Biopharma (NASDAQ:XERS) has a recorded annual revenue of $163.91 million.

Xeris Biopharma (NASDAQ:XERS) has a recorded net income of -$62.26 million. XERS has generated -$0.45 earnings per share over the last four quarters.

Xeris Biopharma's earnings are expected to grow from ($0.41) per share to ($0.22) per share in the next year.

`

More Earnings Resources from MarketBeat



This page (NASDAQ:XERS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners